WILMINGTON, Del., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Seneca Biopharma, Inc. (“Seneca”) (NASDAQ CM: SNCA) regarding possible breaches of fiduciary duties and other violations of law related to Seneca’s agreement to merge with Leading BioSciences, Inc.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-seneca-biopharma-inc.
You may contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.
Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT:
Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
https://rl-legal.com